FDA Approved: VFEND — Supplemental Application (Roerig)

View source ↗

Summary

FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig. The supplement updates the labeling for the antifungal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Esophageal Candidiasis
• Invasive Aspergillosis
• Scedosporiosis

Drugs mentioned

• VFEND (Voriconazole)

Snippet

SUPPL AP for VFEND (VORICONAZOLE)